Email this article 
COVID‑19 Infection and Children: A Comprehensive Review
Abstract
Keywords
Full Text:
PDFReferences
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus
infections and immune responses. J Med Virol 2020;92:424-32.
Chan-Yeung M, Xu R. SARS: Epidemiology. Respirology
;8(Suppl 1) S9-14.
Lee J, Chowell G, Jung E. A dynamic compartmental model for
the Middle East respiratory syndrome outbreak in the Republic
of Korea: A retrospective analysis on control interventions and
superspreading events. J Theor Biology 2016;408:118-26.
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive
number of COVID-19 is higher compared to SARS coronavirus.
J Travel Med 2020;27:taaa021.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G,
Wallrauch C, et al. Transmission of 2019-nCoV infection
from an asymptomatic contact in Germany. N Engl J Med
;382:970-1.
Available from: https://WHOSrAa, www.who.int/emergencies/
diseases/novel-coronavirus-2019/, 2020. s-rAF.
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical
characteristics and intrauterine vertical transmission potential of
COVID-19 infection in nine pregnant women: A retrospective
review of medical records. Lancet 2020;395:809-15.
National Health Commission of the people’s Republic of China,
Handbook NAoTCM, Novel oPaTotPCbt, 5) C-nTv.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.
SARS-CoV-2 viral load in upper respiratory specimens of
infected patients. N Engl J Med 2020;382:1177-9.
Wu JT, Leung K, Leung GM. Nowcasting and forecasting the
potential domestic and international spread of the 2019-nCoV
outbreak originating in Wuhan, China: A modelling study. Lancet
;395:689-97.
Majumder M, Mandl KD. Early transmissibility assessment of a
novel coronavirus in Wuhan, China. China (January 23, 2020).
WHO. Coronavirus disease (COVID-2019) situation reports.
Situation report—55. March 15 hwwidd-scs-r-s--c.
Zhang Q, Cong M, Wang N, Li X, Zhang H, Zhang K,
et al. Association of angiotensin-converting enzyme 2
gene polymorphism and enzymatic activity with essential
hypertension in different gender: A case–control study. Medicine
;97:e12917.
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell
RNA expression profiling of ACE2, the putative receptor of
Wuhan 2019-nCov. BioRxiv 2020.
Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate:
What neonatologist need to know. J Med Virol 2020;92:564-7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical
features of patients infected with 2019 novel coronavirus in
Wuhan, China. The Lancet 2020;395(:497-506.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al.
Epidemiological and clinical characteristics of 99 cases of 2019
novel coronavirus pneumonia in Wuhan, China: A descriptive
study. Lancet 2020;395(:507-13.
Singhal T. A review of coronavirus disease-2019 (COVID-19).
Indian J Pediatr 2020;87:281-6.
Available from: https://www.worldometers. COAa, 2020. icAF.
Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, et al. Use of
chest CT in combination with negative RT-PCR assay for the
novel coronavirus but high clinical suspicion. Radiology
;295:22-3.
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al.
Clinical findings in a group of patients infected with the 2019
novel coronavirus (SARS-Cov-2) outside of Wuhan, China:
Retrospective case series. Bmj. 2020;368.
Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan YP, et al.
A rapid advice guideline for the diagnosis and treatment of 2019
novel coronavirus (2019-nCoV) infected pneumonia (standard
version). Military Med Res 2020;7:4.
Zhang L, Liu Y. Potential interventions for novel coronavirus in
China: A systematic review. J Med Virol 2020;95:479-90.
Biot C, Daher W, Chavain N, Fandeur T, Khalife J, Dive D,
et al. Design and synthesis of hydroxyferroquine derivatives with
antimalarial and antiviral activities. J Med Chem 2006;49:2845-9.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M,
et al. Hydroxychloroquine and azithromycin as a treatment of
COVID-19: Results of an open-label non-randomized clinical
trial. Int J Antimicrob Agents 2020:105949. doi: 10.1016/j.
ijantimicag. 2020.105949.
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA,
Lofgren SM, Okafor EC, et al. A randomized trial of
hydroxychloroquine as postexposure prophylaxis for Covid-19.
N Engl J Med 2020. doi: 10.1056/NEJMoa2016638.
Day M. Covid-19: European drugs agency to review safety of
ibuprofen. BMJ 2020;368:m1168.
Que T, Wong V, Yuen K. Treatment of severe acute respiratory
syndrome with lopinavir/ritonavir: A multicentre retrospective
matched cohort study. Hong Kong Med J 2003;9:399-406.
Chong YP, Song JY, Seo YB, Choi JP, Shin HS, Team RR.
Antiviral treatment guidelines for Middle East respiratory
syndrome. Infect Chemother 2015;47:212-22.
Wang Y, Zhu LQ. Pharmaceutical care recommendations for
antiviral treatments in children with coronavirus disease 2019.
World J Pediatr 2020;16:271-4.
Falzarano D, De Wit E, Rasmussen AL, Feldmann F, Okumura A,
Scott DP, et al. Treatment with interferon-α2b and ribavirin
improves outcome in MERS-CoV–infected rhesus macaques. Nat
Med 2013;19:1313-7.
Chen Z, Fu J, Shu Q, Chen Y, Hua C, Li F, et al. [Diagnosis and
treatment recommendation for pediatric coronavirus disease-19].
Zhejiang Da Xue Xue Bao Yi Xue Ban 2020;49:1-8.
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS,
Kalil AC, et al. Remdesivir for the treatment of Covid-19—
preliminary report. N Engl J Med 2020. doi: 10.1056/
NEJMoa2007764.
Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in
BCG-vaccinated and unvaccinated young adults. JAMA
;323:2340-1.
Adhikari SP, Meng S, Wu Y-J, Mao YP, Ye RX, Wang QZ,
et al. Epidemiology, causes, clinical manifestation and diagnosis,
prevention and control of coronavirus disease (COVID-19)
during the early outbreak period: A scoping review. Infect Dis
Poverty 2020;9:1-12.
Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, et al. The first
days of novel coronavirus (SARS-CoV-2) outbreak: Recent
advances, prevention, and treatment. Int J Environ Res Public
Health 2020;17:2323.
Panigrahi SK, Pathak VK, Kumar MM, Raj U, Priya PK.
Covid-19 and mobile phone hygiene in healthcare settings. BMJ
Glob Health 2020;5:e002505.
[The epidemiological characteristics of an outbreak of 2019
novel coronavirus diseases (COVID-19) in China]. Zhonghua
Liu Xing Bing Xue Za Zhi. 2020;41:145-51.
Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19)
in Italy. JAMA 2020. doi: 10.1001/jama. 2020.4344.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with
coronavirus disease in China. Pediatrics. 2020.
Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, et al. A case series
of children with 2019 novel coronavirus infection: Clinical and
epidemiological features. Clin Infect Dis 2020. doi: 10.1093/cid/
ciaa198.
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children.
N Engl J Med 2020;382:1663-5.
United SOAPwCDC-, States FM, 2020. (CDC COVID-19
Response Team). Morbidity and Mortality, Weekly
Report March 18.
Chen F, Liu Z, Zhang F, Xiong RH, Chen Y, Cheng XF, et al.
Frist case of severe childhood novel coronavirus pneumonia in
China. Zhonghua Er Ke Za Zhi 2020;58:E005.
Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A,
et al. Epidemiology, clinical features, and disease severity
in patients with coronavirus disease 2019 (COVID-19) in a
children’s hospital in New York City, New York. JAMA Pediatr
:e202430.
Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical
characteristics of 24 asymptomatic infections with COVID-19
screened among close contacts in Nanjing, China. Sci China Life
Sci 2020;63:76-11.
Cao Q, Chen Y-C, Chen C-L, Chiu C-H. SARS-CoV-2 infection
in children: Transmission dynamics and clinical characteristics.
J Formos Med Assoc 2020;119:670-3.
Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological
and clinical features of the emerging 2019 novel coronavirus
pneumonia (COVID-19) implicate special control measures.
J Med Virol 2020;92:568-76.
Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT
features in pediatric patients with COVID-19 infection: Different
points from adults. Pediatr Pulmonol 2020;55:1169-74.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N,
Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends
on ACE2 and TMPRSS2 and is blocked by a clinically proven
protease inhibitor. Cell 2020;181:271-80.e8.
Yonker LM, Shen K, Kinane TB. Lessons unfolding from
pediatric cases of COVID-19 disease caused by SARS-CoV-2
infection. Pediatr Pulmonol 2020;55:1085-6.
Henry BM, Lippi G, Plebani M. Laboratory abnormalities in
children with novel coronavirus disease 2019. Clin Chem Lab
Med 2020;58:1135-8.
Shen Q, Guo W, Guo T, Li J, He W, Ni S, et al. Novel
coronavirus infection in children outside of Wuhan, China.
Pediatr Pulmonol 2020;55:1424-9.
Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, et al. A human
neutralizing antibody targets the receptor binding site of SARSCoV-2. Nature 2020;584(7819):120-4.
CDC COVID-19 Response Team. Coronavirus Disease 2019 in
Children—United States, February 12–April 2, 2020. MMWR
Morb Mortal Wkly Rep 2020;69:422-6.
Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H,
Mirjalili SR, Behforouz A, et al. Vertical transmission
of coronavirus disease 19 (COVID-19) from infected
pregnant mothers to neonates: A review. Fetal Pediatr
Pathol 2020;39:246-50.
Ludvigsson JF. Systematic review of COVID-19 in children
show milder cases and a better prognosis than adults. Acta
Paediatr 2020;109:1088-95.
Chen S, Huang B, Luo D, Li X, Yang F, Zhao Y, et al. Pregnant
women with new coronavirus infection: A clinical characteristics
and placental pathological analysis of three cases. Zhonghua
Bing Li Xue Za Zhi 2020,8;49(5):418-23.
Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, et al.
Analysis of the pregnancy outcomes in pregnant women with
COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi
;55:166-171.
Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical
features and obstetric and neonatal outcomes of pregnant patients
with COVID-19 in Wuhan, China: A retrospective, single-centre,
descriptive study. Lancet Infect Dis 2020;20:559-64.